Paul Riley/LinkedIn
Jul 18, 2026, 11:54
Paul Riley: Presenting STAR Max3 at ISTH 2026
Paul Riley, Scientific Marketing Manager at Diagnostica Stago, shared a post on LinkedIn:
“Showing our FDA submission data for the STAR Max3 at ISTH – always a privilege to attend and present at ISTH, with this meeting especially meaningful because it is taking place in Paris, the location for my first ISTH 25 years ago!
A quarter century of being witness to all of the change in the field and also International Society on Thrombosis and Haemostasis (ISTH)‘s growth as an organization clinical laboratory wtd2026.
I really do feel privileged to be involved with ISTH during these times.
I will miss Paris but will make it back soon enough.”
Stay Updated with the Latest ISTH 2026 Updates on Hemostasis Today.
-
Sep 4, 2026, 02:44Ahmed Kotb: Emergency Management of Critical Bleeding in ITP
-
Sep 4, 2026, 02:30Mario Jimenez: KDIGO 2026 – A More Proactive Approach to IV Iron in Hemodialysis
-
Sep 4, 2026, 02:18Edgardo Alania: Edoxaban in Intracranial Haemorrhage Survivors with AF
-
Sep 3, 2026, 20:33Jennifer Weinstein: Happy to Share Our New Work on the Patient Experience in VWD at the NBDF Conference
-
Sep 3, 2026, 20:31Guillaume Courbon: New Publication on Erythroid-Produced FGF23 and Its Role in Anemia
-
Sep 3, 2026, 20:30Phuong Khanh Morrow: FDA Approval Marks an Important Step Forward for the PV Community
-
Sep 3, 2026, 20:29Sarah Robins: Happy to Share This Portrait Film I Voiced for the NNHHF
-
Sep 3, 2026, 20:27Mireille Muller: Europe Needs More Plasma Donors
-
Sep 3, 2026, 17:54Tareq Abadl: Extravascular Hemolysis The High-Yield Guide